Financial statements Susan- Pharm
Balance sheet data of SUSAN- PHARM
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 188 173,47 | 214 509,80 |
| A. Fixed assets | - | - |
| B. Current assets | 188 173,47 | 214 509,80 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 188 173,47 | 214 509,80 |
| A. Equity | 66 700,81 | 92 713,33 |
| B. Liabilities and provisions for liabilities | 121 472,66 | 121 796,47 |
| I. Long-term liabilities | 875,00 | 0,00 |
| II. Short-term liabilities | 120 597,66 | 121 796,47 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.